All Topics

Subscribe
Article
BBB National Programs Releases Results Of Green Claims Study
A new research study commissioned by BBB National Programs reveals how consumers interpret environmental marketing claims and demonstrates that qualified, specific green claims help consumers make more accurate judgments about a company's environmental practices without diminishing brand appeal. The study found that broad, unqualified environmental claims can create a 'halo effect' leading consumers to infer benefits that were never stated.
United States Consumer
GA
Global Advertising Lawyers Alliance (GALA)
Article
The Supreme Court May Decide If Cannabis-Related Residency Requirements Are Unconstitutional
A Michigan cannabis entrepreneur has petitioned the U.S. Supreme Court to resolve a critical circuit split on whether states can constitutionally discriminate against non-residents in cannabis licensing programs under the dormant commerce clause. The case challenges residency requirements that have denied out-of-state applicants access to state-legal marijuana markets in Washington, California, and numerous other jurisdictions. With prominent constitutional scholar Erwin Chemerinsky leading the petition and
United States Government
HS
Harris Sliwoski
Article
SEC Proposes Rescinding The Federal Shareholder Proposal Rule
The SEC has proposed rescinding Rule 14a-8, which currently allows eligible shareholders to include proposals in company proxy statements, and expanding corporate discretionary voting authority over shareholder proposals. This fundamental shift would replace the uniform federal framework with state law and private ordering, potentially transforming how shareholders engage with corporate governance and exercise their voting rights.
United States Commercial
GP
Goodwin Procter LLP
Article
Data Ownership In Life Sciences Transactions Why It Matters More Than Ever In The Age Of AI
As pharmaceutical and biotech companies increasingly leverage AI and machine learning to accelerate drug discovery and develop personalized therapies, data has become one of the most valuable assets in life sciences transactions. Understanding the legal and commercial implications of data scope, ownership, and usage restrictions is now essential for dealmakers navigating this evolving landscape where proprietary research...
United States Healthcare
BS
Ballard Spahr LLP
See more